Welcome to the Kids' Library!

Search for books, movies, music, magazines, and more.

Back to Search Results

Available items only

Previous Record Next Record

Title Guidance for industry : postmarketing adverse event reporting for medical products and dietary supplements during an influenza pandemic.

Imprint

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of Counterterrorism and Emerging Threats : Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research : Center for Devices and Radiological Health : Center for Food Safety and Applied Nutrition, [2008]

Connect to
Connect to https://permanent.fdlp.gov/LPS114222/UCM080534.pdf

Copies

Location	Call No.	OPAC Message	Status
Axe Federal Documents Online	HE 20.4002:AD 9/5	---	Available

Description	1 online resource (12 pages)
	text txt rdacontent
	computer c rdamedia
	online resource cr rdacarrier
Note	"Draft guidance."
	"Procedural."
	"December 2008."
Subject	Drugs -- Side effects -- Reporting -- Government policy -- United States.
	Dietary supplements -- Government policy -- United States.
	Influenza.
Added Author	United States. Food and Drug Administration. Office of Counterterrorism and Emerging Threats.
	Center for Drug Evaluation and Research (U.S.)
	Center for Biologics Evaluation and Research (U.S.)
	Center for Devices and Radiological Health (U.S.)
	Center for Food Safety and Applied Nutrition (U.S.)
Added Title	Postmarketing adverse event reporting for medical products and dietary supplements during an influenza pandemic
Gpo Item No.	0475 (online)
Sudoc No.	HE 20.4002:AD 9/5